Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells.

Abstract:

:Increased expression of cyclooxygenase (COX) and overproduction of prostaglandins (PGs) have been implicated in the development and progression of colorectal cancer (CRC). Nonsteroidal anti-inflammatory agents (NSAIDS) inhibit growth of various CRC cell lines by both COX-dependent and COX-independent pathways. To specifically examine the effect of COX and PGs on proliferation in CRC cells, we introduced an antisense COX-2 cDNA construct under the control of a tetracycline (Tc)-inducible promoter into a CRC cell line, HCA-7, Colony 29 (HCA-7) that expresses COX and produces PGs. In the presence of Tc, PG production in COX-depleted cells was reduced 99.8% compared with either uninduced transfectants or parental HCA-7 cells. This decrease in PG production was associated with a concomitant 60% reduction in DNA replication. Subsequently, we examined the effects of various PGs to modulate cell growth in COX-depleted HCA-7 or COX-null HCT-15 cells by quantifying [3H]thymidine incorporation and/or growth in collagen gels. We report that J-series cyclopentenone PGs, particularly PGJ2 and 15-deoxy-delta12,14-PGJ2, induce proliferation of these cells at nanomolar concentrations. Lipids extracted from parental HCA-7 cell conditioned medium stimulated mitogenesis in COX-depleted HCA-7 cells and COX-null HCT-15 cells. Using chromatographic and mass spectrometric approaches, we were able to detect PGJ2 in conditioned medium from parental HCA-7 cells. Taken together, these findings implicate a role for cyclopentenone PGs in CRC cell proliferation.

journal_name

Cancer Res

journal_title

Cancer research

authors

Chinery R,Coffey RJ,Graves-Deal R,Kirkland SC,Sanchez SC,Zackert WE,Oates JA,Morrow JD

subject

Has Abstract

pub_date

1999-06-01 00:00:00

pages

2739-46

issue

11

eissn

0008-5472

issn

1538-7445

journal_volume

59

pub_type

杂志文章
  • Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers.

    abstract::Streptavidin (SA)-biotin pretargeted radioimmunotherapy (PRIT) that targets CD20 in non-Hodgkin lymphoma (NHL) exhibits remarkable efficacy in model systems, but SA immunogenicity and interference by endogenous biotin may complicate clinical translation of this approach. In this study, we engineered a bispecific fusio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-0571

    authors: Green DJ,Frayo SL,Lin Y,Hamlin DK,Fisher DR,Frost SH,Kenoyer AL,Hylarides MD,Gopal AK,Gooley TA,Orozco JJ,Till BG,O'Steen S,Orcutt KD,Wilbur DS,Wittrup KD,Press OW

    更新日期:2016-11-15 00:00:00

  • Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells.

    abstract::Vitamin E succinate (VES), a derivative of the fat-soluble vitamin D-alpha-tocopherol (vitamin E), inhibited growth and induced apoptotic cell death of estrogen receptor-negative human breast cancer cells. VES-induced apoptosis in MDA-MB-231 and SKBR-3 cells occurred through a Fas pathway. Total protein levels of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Turley JM,Fu T,Ruscetti FW,Mikovits JA,Bertolette DC 3rd,Birchenall-Roberts MC

    更新日期:1997-03-01 00:00:00

  • Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity.

    abstract::Aggressive tumor growth, diffuse tissue invasion, and neurodegeneration are hallmarks of malignant glioma. Although glutamate excitotoxicity is considered to play a key role in glioma-induced neurodegeneration, the mechanism(s) controlling this process is poorly understood. Astrocyte elevated gene-1 (AEG-1) is an onco...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-0782

    authors: Lee SG,Kim K,Kegelman TP,Dash R,Das SK,Choi JK,Emdad L,Howlett EL,Jeon HY,Su ZZ,Yoo BK,Sarkar D,Kim SH,Kang DC,Fisher PB

    更新日期:2011-10-15 00:00:00

  • Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.

    abstract::The complement system is important in immunosurveillance against tumors. However, malignant cells are usually resistant to complement-mediated lysis. In this study, we examine the expression of factor H, an inhibitor of complement activation, and factor H-like protein 1 (FHL-1), its alternatively spliced form, in lung...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-2328

    authors: Ajona D,Castaño Z,Garayoa M,Zudaire E,Pajares MJ,Martinez A,Cuttitta F,Montuenga LM,Pio R

    更新日期:2004-09-01 00:00:00

  • Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b.

    abstract::We have synthesized fluoromycin (FLM), a novel fluorescein-labeled derivative of talisomycin S10b (TLM S10b), and used it to evaluate cellular drug accumulation and distribution in bleomycin (BLM)-sensitive and -resistant cell lines. The fluorescence intensity of FLM was 300- to 400-fold greater than that of BLM A2, T...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mistry JS,Jani JP,Morris G,Mujumdar RB,Reynolds IJ,Sebti SM,Lazo JS

    更新日期:1992-02-01 00:00:00

  • Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity.

    abstract::Despite the impressive results obtained in animal models, the clinical use of tumor necrosis factor-alpha (TNF) as an anticancer drug is limited by severe toxicity. We have shown previously that targeted delivery of TNF to aminopeptidase N (CD13), a marker of angiogenic vessels, improved the therapeutic index of this ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.can-03-1753

    authors: Curnis F,Gasparri A,Sacchi A,Longhi R,Corti A

    更新日期:2004-01-15 00:00:00

  • DINC 2.0: A New Protein-Peptide Docking Webserver Using an Incremental Approach.

    abstract::Molecular docking is a standard computational approach to predict binding modes of protein-ligand complexes by exploring alternative orientations and conformations of the ligand (i.e., by exploring ligand flexibility). Docking tools are largely used for virtual screening of small drug-like molecules, but their accurac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-0511

    authors: Antunes DA,Moll M,Devaurs D,Jackson KR,Lizée G,Kavraki LE

    更新日期:2017-11-01 00:00:00

  • Interleukin 4 receptor expression on human lung tumors and normal lung.

    abstract::Interleukin 4 (IL-4) receptors were detected by a monoclonal antibody on tumor cells of 10 of 29 squamous cell carcinomas and 6 of 17 adenocarcinomas of the lung. None of the small cell carcinomas or carcinoid tumors stained. Parallel sections stained for epidermal growth factor receptors showed that all but 2 of the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tungekar MF,Turley H,Dunnill MS,Gatter KC,Ritter MA,Harris AL

    更新日期:1991-01-01 00:00:00

  • Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.

    abstract::Sixteen clones (RASK-1 to -16) of murine monoclonal antibodies were raised against ras Mr 21,000 protein (p21). The p21 produced by Escherichia coli with inserted v-Ki-ras genes was used as immunogen. RASK-1 was found to be specific for Ki-ras p21, whereas RASK-2 to -16 reacted with the p21s of Ki-, N-, and Ha-ras gen...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshida K,Hamatani K,Koide H,Ikeda H,Nakamura N,Akiyama M,Tsuchiyama H,Nakayama E,Shiku H

    更新日期:1988-10-01 00:00:00

  • Mutations in human O6-alkylguanine-DNA alkyltransferase imparting resistance to O6-benzylguanine.

    abstract::O6-Benzylguanine is an inactivator of O6-alkylguanine-DNA alkyltransferases (AGT) which is currently entering clinical trials as an agent improving the cancer chemotherapeutic activity of chloroethylnitrosoureas and other alkylating agents. O6-Benzylguanine acts by virtue of its ability to serve as a substrate for the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crone TM,Goodtzova K,Edara S,Pegg AE

    更新日期:1994-12-01 00:00:00

  • Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells.

    abstract::Prostate cancer is the most commonly diagnosed noncutaneous neoplasm and second most common cause of cancer-related mortality in western men. To investigate the mechanisms of prostate cancer development and progression, we did expression profiling of human prostate cancer and benign tissues. We show that the SOX4 is o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3055

    authors: Liu P,Ramachandran S,Ali Seyed M,Scharer CD,Laycock N,Dalton WB,Williams H,Karanam S,Datta MW,Jaye DL,Moreno CS

    更新日期:2006-04-15 00:00:00

  • Induced secretion of a Mr 46,000 protein by cultured human hepatoma cells treated with tumor promoters.

    abstract::Human hepatoma cells, HuH-6 Cl-5, were treated with 12-O-tetradecanoylphorbol-13-acetate at concentrations of 1 ng/ml to 10 micrograms/ml for 6 h in the presence of [35S]methionine. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the labeled proteins secreted into the medium showed that this t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yoneda Y,Fujiki H,Moore RE,Uchida T

    更新日期:1985-05-01 00:00:00

  • Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas.

    abstract::Sunitinib is an antiangiogenic therapy given as a first-line treatment for renal cell carcinoma (RCC). While treatment improves progression-free survival, most patients relapse. We hypothesized that patient relapse can stem from the development of a lymphatic network driven by the production of the main growth factor ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-3088

    authors: Dufies M,Giuliano S,Ambrosetti D,Claren A,Ndiaye PD,Mastri M,Moghrabi W,Cooley LS,Ettaiche M,Chamorey E,Parola J,Vial V,Lupu-Plesu M,Bernhard JC,Ravaud A,Borchiellini D,Ferrero JM,Bikfalvi A,Ebos JM,Khabar KS,Grép

    更新日期:2017-03-01 00:00:00

  • In vitro immunization against human tumor cells with tumor cell fractions.

    abstract::Tumor cell fractions isolated from tumor lines SH-3 (breast carcinoma) and RPMI-7932 (malignant melanoma) by differential centrifugations were capable of transforming lymphocytes into cytotoxic effector cells. Lymphocytes cultured alone in human AB plasma did not become cytotoxic to tumor cells. However, when cultured...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sharma B

    更新日期:1977-12-01 00:00:00

  • Casein kinase 1ε promotes cell proliferation by regulating mRNA translation.

    abstract::Deregulation of translation initiation factors contributes to many pathogenic conditions, including cancer. Here, we report the definition of a novel regulatory pathway for translational initiation with possible therapeutic import in cancer. Specifically, we found that casein kinase 1ε (CK1ε) is highly expressed in br...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1175

    authors: Shin S,Wolgamott L,Roux PP,Yoon SO

    更新日期:2014-01-01 00:00:00

  • A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients.

    abstract::In cancer cell lines and rodent models, calcium and vitamin D favorably modulate cell proliferation, differentiation, and apoptosis in colonic epithelia. These effects may be modulated by local expression of the calcium receptor (CaR), the vitamin D receptor (VDR), and the P450 cytochromes, CYP27B1 and CYP24A1; howeve...

    journal_title:Cancer research

    pub_type: 杂志文章,随机对照试验

    doi:10.1158/0008-5472.CAN-10-1560

    authors: Ahearn TU,McCullough ML,Flanders WD,Long Q,Sidelnikov E,Fedirko V,Daniel CR,Rutherford RE,Shaukat A,Bostick RM

    更新日期:2011-01-15 00:00:00

  • Effects of tumor cell viability and inoculum density on growth parameters in the human tumor, soft-agar clonogenic assay.

    abstract::Four hundred and forty-seven human tumor specimens were accessioned and processed for clonogenic assay, yielding 374 specimens, representing 23 different histiotypes, adequate for culture. Different levels of viable cell inoculum density produced contrasting effects between 255 solid tumors as compared to 72 malignant...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Page RH,Tilchen EJ,Davis HL

    更新日期:1988-07-15 00:00:00

  • PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo.

    abstract::We show here that PRL-3 protein is expressed in fetal heart, developing blood vessels, and pre-erythrocytes but not in their mature counterparts. These observations imply that PRL-3 may be involved in the early development of the circulatory system. Because PRL-3 mRNA had been reported to be consistently elevated in m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0726

    authors: Guo K,Li J,Wang H,Osato M,Tang JP,Quah SY,Gan BQ,Zeng Q

    更新日期:2006-10-01 00:00:00

  • Aptamer identification of brain tumor-initiating cells.

    abstract::Glioblastomas display cellular hierarchies with self-renewing tumor-initiating cells (TIC), also known as cancer stem cells, at the apex. Although the TIC hypothesis remains controversial and the functional assays to define the TIC phenotype are evolving, we and others have shown that TICs may contribute to therapeuti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-4556

    authors: Kim Y,Wu Q,Hamerlik P,Hitomi M,Sloan AE,Barnett GH,Weil RJ,Leahy P,Hjelmeland AB,Rich JN

    更新日期:2013-08-01 00:00:00

  • Lesions of the rete testis in mice exposed prenatally to diethylstilbestrol.

    abstract::Adenocarcinoma of the rete testis is an exceptionally rare and malignant testicular neoplasm. Although treatment of pregnant women with diethylstilbestrol (DES) results in reproductive tract abnormalities in their male offspring, increased incidence of testicular tumors has not been verified. However, recently three c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Newbold RR,Bullock BC,McLachlan JA

    更新日期:1985-10-01 00:00:00

  • Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells.

    abstract::Development of resistance to tamoxifen is a serious problem in treatment of breast cancer patients. Although the mechanisms for development of resistance are unclear, an altered expression of alternatively spliced estrogen receptor (ER) mRNA has been suggested to be involved. We have looked for differential expression...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Madsen MW,Reiter BE,Larsen SS,Briand P,Lykkesfeldt AE

    更新日期:1997-02-15 00:00:00

  • Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.

    abstract::Pharmacokinetic studies of 5-fluorouracil (5-FUra) were performed on 18 patients divided into three groups: seven patients were given 5-FUra i.v. by rapid injection; five patients received the drug p.o.; and six patients were treated by continuous i.v. infusion for 96 hr. The results showed rapid i.v. injection to be ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fraile RJ,Baker LH,Buroker TR,Horwitz J,Vaitkevicius VK

    更新日期:1980-07-01 00:00:00

  • Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines.

    abstract::While colony formation assays provide sensitive indices of tumor cell proliferation and growth inhibition imposed by many chemotherapeutic agents, drugs which require metabolic activation lack activity in such assays. In the present study, we have utilized freshly isolated rat hepatocytes for the activation of drugs w...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alley MC,Powis G,Appel PL,Kooistra KL,Lieber MM

    更新日期:1984-02-01 00:00:00

  • Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer.

    abstract::The estrogen receptor (ER) is a nuclear protein with a hormone- and a DNA-binding domain. We examined the DNA binding of ER in MCF-7 cells and 79 primary breast cancers by gel mobility shift assay using as a probe the estrogen response element (ERE). The mobility shift assay showed saturable, specific binding of ER to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Foster BD,Cavener DR,Parl FF

    更新日期:1991-07-01 00:00:00

  • Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

    abstract::Immune checkpoint therapies exhibit impressive efficacy in some patients with melanoma or lung cancer, but the lack of response in most cases presses the question of how general efficacy can be improved. In addressing this question, we generated a preclinical tumor model to study anti-PD-1 resistance by in vivo passag...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-3142

    authors: Wang X,Schoenhals JE,Li A,Valdecanas DR,Ye H,Zang F,Tang C,Tang M,Liu CG,Liu X,Krishnan S,Allison JP,Sharma P,Hwu P,Komaki R,Overwijk WW,Gomez DR,Chang JY,Hahn SM,Cortez MA,Welsh JW

    更新日期:2017-02-15 00:00:00

  • Mouse intestinal goblet cells expressing SV40 T antigen directed by the MUC2 mucin gene promoter undergo apoptosis upon migration to the villi.

    abstract::Mucinous colorectal cancers exhibit a characteristic set of molecular genetic alterations and may be derived from progenitor cells committed to the goblet cell lineage. Previously, we demonstrated that the MUC2 mucin gene promoter drives transgene reporter expression with high specificity in small intestinal goblet ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gum JR Jr,Hicks JW,Gillespie AM,Rius JL,Treseler PA,Kogan SC,Carlson EJ,Epstein CJ,Kim YS

    更新日期:2001-04-15 00:00:00

  • Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

    abstract::Mutations in the adenomatous polyposis coli (APC) gene and K-ras occur in the majority of human colorectal cancers. Loss of functional APC protein activates the Wnt signal transduction pathway, allowing the nuclear accumulation of beta-catenin, which then binds to T-cell factor-4 (Tcf-4), causing increased transcripti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Araki Y,Okamura S,Hussain SP,Nagashima M,He P,Shiseki M,Miura K,Harris CC

    更新日期:2003-02-01 00:00:00

  • Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway.

    abstract::Glycine N-methyltransferase (GNMT) affects genetic stability by (a) regulating the ratio of S-adenosylmethionine to S-adenosylhomocystine and (b) binding to folate. Based on the identification of GNMT as a 4 S polyaromatic hydrocarbon-binding protein, we used liver cancer cell lines that expressed GNMT either transien...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3726

    authors: Chen SY,Lin JR,Darbha R,Lin P,Liu TY,Chen YM

    更新日期:2004-05-15 00:00:00

  • Phenol-soluble nonhistone chromatin proteins in chronic lymphocytic leukemia.

    abstract::The altered gene expression seen in cancer could relate to differences in nonhistone chromatin proteins between normal and malignant tumor cells. Phenol-soluble nonhistone chromatin proteins were isolated from human normal and leukemic (chronic lymphocytic leukemia) B-cells, as well as long-term cultured human B-lymph...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jones CA,Hesse L,Muzik H,Jerry LM

    更新日期:1984-05-01 00:00:00

  • Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.

    abstract::A single i.p. injection of cyclophosphamide (CY), 15 mg/kg, was shown previously to be curative if administered to BALB/c mice 10 to 16 days post-MOPC-315 tumor inoculation when the tumors reached 20 to 25 mm (large tumors) but not if administered to mice four days post-tumor inoculation when their tumors were nonpalp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hengst JC,Mokyr MB,Dray S

    更新日期:1981-06-01 00:00:00